Last updated on 29 Nov 2022
Owner Info
Revance Therapeutics, Inc.
7555 Gateway Blvd.
Newark CA 94560, UNITED STATES OF AMERICA
Serial Number
2191189 filed on 16 Apr 2021
Correspondent
Maren C. Perry King & Spalding LLP
1185 Avenue of the Americas,
New York NY 10036,
UNITED STATES OF AMERICA
2191189
16 Apr 2021
16 Apr 2031
FIGURATIVE
19 Oct 2020
US
Status Date | Action Taken |
---|---|
29th Nov 2022 | International Registration in Australia Protected After Adverse (No amendments) correspondence sent |
28th Nov 2022 | International Registration in Australia Protected After Adverse (No amendments) correspondence sent |
28th Nov 2022 | IP Right Registration Published |
28th Nov 2022 | Status change to Registered/Protected |
21st Sept 2022 | Application Accepted correspondence sent |
20th Sept 2022 | Application Accepted correspondence sent |
20th Sept 2022 | IP Right has been Examined |
20th Sept 2022 | IP Right Acceptance Published |
20th Sept 2022 | Status change to Accepted |
15th Sept 2022 | Examination Response Received |